saying that though, an argument would be it done precisely nothing in the pervious 12 months to Increase holders value.
CSL possible pull back to low $200's, page-33
-
-
- There are more pages in this discussion • 550 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$307.26 |
Change
-1.300(0.42%) |
Mkt cap ! $149.1B |
Open | High | Low | Value | Volume |
$307.48 | $307.69 | $307.12 | $10.08M | 32.79K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11 | $307.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$307.36 | 9 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 113 | 331.560 |
1 | 58 | 323.990 |
15 | 3411 | 323.980 |
2 | 560 | 323.670 |
4 | 2494 | 320.250 |
Price($) | Vol. | No. |
---|---|---|
277.670 | 25 | 1 |
277.680 | 98 | 3 |
277.710 | 420 | 1 |
289.890 | 96 | 3 |
290.000 | 651 | 2 |
Last trade - 10.04am 16/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online